HZNP - Horizon Therapeutics Plc
IEX Last Trade
116.3
12.240 10.525%
Share volume: 0
Last Updated: Thu 05 Oct 2023 08:08:28 PM CEST
Pharmaceutical Preparation Manufacturing :
2.72%
PREVIOUS CLOSE
CHG
CHG%
$104.06
0.00
0.00%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | |
| Report Date | 2022-05-04 | 2022-08-03 | 2022-11-02 | 2023-03-01 | 2023-05-03 | 2023-08-08 | |
| Total revenue | 885.245 M | 876.411 M | 925.359 M | 942.029 M | 832.059 M | 944.959 M | |
| Cost of revenue | 215.062 M | 230.216 M | 234.132 M | 240.787 M | 208.563 M | 219.958 M | |
| Gross profit | 670.183 M | 646.195 M | 691.227 M | 701.242 M | 623.496 M | 725.001 M | |
| -3.58% | 6.97% | 1.45% | -11.09% | 16.28% | |||
| Operating expenses | 475.866 M | 501.467 M | 511.621 M | 490.060 M | 587.502 M | 584.160 M | |
| Selling general and admin | 372.734 M | 398.221 M | 397.563 M | 372.534 M | 453.354 M | 434.125 M | |
| Research and development | 103.132 M | 103.246 M | 114.058 M | 117.526 M | 134.148 M | 150.035 M | |
| Total expenses | 690.928 M | 731.683 M | 745.753 M | 768.097 M | 796.065 M | 804.118 M | |
| 5.90% | 1.92% | 3.00% | 3.64% | 1.01% | |||
| Operating income | 194.317 M | 144.728 M | 179.606 M | 173.932 M | 35.994 M | 140.841 M | |
| Ebit | 194.317 M | 144.728 M | 179.606 M | 173.932 M | 35.994 M | 140.841 M | |
| Pretax income | 172.739 M | 64.787 M | 135.081 M | 154.329 M | 19.202 M | 135.252 M | |
| -62.49% | 108.50% | 14.25% | -87.56% | 604.36% | |||
| Income tax | -31.522 M | 3.813 M | -758.000 K | 33.921 M | -35.482 M | 8.181 M | |
| Net income basic | 204.261 M | 60.974 M | 135.839 M | 120.408 M | 54.684 M | 127.071 M | |
| -70.15% | 122.78% | -11.36% | -54.58% | 132.37% | |||
| Net income | 204.261 M | 60.974 M | 135.839 M | 120.408 M | 54.684 M | 127.071 M | |
| -70.15% | 122.78% | -11.36% | -54.58% | 132.37% |